cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
epirubicin ebewe 2 mg/ml koncentrat za raztopino za infundiranje
ebewe pharma - epirubicin - koncentrat za raztopino za infundiranje - epirubicin 1,88 mg / 1 ml - epirubicin
oxamed 5 mg/ml prašek za raztopino za infundiranje
prašek za raztopino za infundiranje - oksaliplatin
epirubicin ebewe 2 mg/ml koncentrat za raztopino za infundiranje
ebewe pharma - epirubicin - koncentrat za raztopino za infundiranje - epirubicin 1,88 mg / 1 ml - epirubicin
oxamed 5 mg/ml prašek za raztopino za infundiranje
prašek za raztopino za infundiranje - oksaliplatin
oxamed 5 mg/ml prašek za raztopino za infundiranje
prašek za raztopino za infundiranje - oksaliplatin
ciambra
menarini international operations luxembourg s.a. - pemetreksed dinatrijev hemipentahidrat - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra je označen kot monotherapy za vzdrževanje zdravljenje lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologijo pri bolnikih, katerih bolezen ni napredovala takoj po platinum, ki temelji kemoterapijo. ciambra je označen kot monotherapy na drugi liniji zdravljenja bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologija.
lonsurf
les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
bilador 10 mg orodisperzibilne tablete
menarini international o.l.s.a. - bilastin - orodisperzibilna tableta - bilastin 10 mg / 1 tableta - bilastin
nolvadex 10 mg filmsko obložene tablete
astrazeneca uk limited - tamoksifen - filmsko obložena tableta - tamoksifen 10 mg / 1 tableta - tamoksifen